Advice
Following an abbreviated submission:
budesonide 9mg gastro-resistant granules (Budenofalk®) is accepted for use within NHS Scotland.
Indication under review: induction of remission in patients with active collagenous colitis.
Budesonide gastro-resistant granules provides a once daily alternative to budesonide gastro-resistant 3mg capsules (which are given three times daily) at no additional cost. The granules may have advantages for patients who have difficulty swallowing.
Download detailed advice78KB (PDF)
Medicine details
- Medicine name:
- budesonide 9mg gastro-resistant granules (Budenofalk) Abbreviated
- SMC ID:
- 831/12
- Indication:
- Induction of remission in patients with active collagenous colitis.
- Pharmaceutical company
- Dr Falk Pharma UK
- BNF chapter
- Gastro-intestinal system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 14 January 2013